HFCL vs MARKSANS: Stock Comparison
Head-to-head financial and trading comparison between HFCL Limited (HFCL) and Marksans Pharma Limited (MARKSANS) in the Cross-Sector Peers sector.
HFCL
NSE: HFCLMARKSANS
NSE: MARKSANSKey Metrics Comparison Table
| Metric | HFCL | MARKSANS | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹226.27 | ₹309.10 | — |
| 1-Year Price Return | +142.52% | +74.73% | HFCL (67.79% higher) |
| 52-Week High | ₹251.47 | ₹347.60 | — |
| 52-Week Low | ₹93.30 | ₹176.77 | — |
| 30-Day Annualized Volatility | 50.72% | 42.37% | MARKSANS (Steadier) |
| 30-Day Average Daily Volume | 22,764,811 | 2,394,723 | HFCL (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between HFCL and MARKSANS, which stock gave better returns over the last year?
HFCL has outperformed MARKSANS over the past 12 months with a gain of 142.52% compared to 74.73%.
Which stock is less volatile: HFCL or MARKSANS?
MARKSANS demonstrated lower price volatility (42.37% annualized) compared to HFCL (50.72%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of HFCL vs MARKSANS?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are HFCL and MARKSANS direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.